TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30946602

Group type: EXPERIMENTAL
Intervention: Mental imagery training combined with electromyogram-triggered neuromuscular electrical stimulation
Number of subjects: 68

Group type: COMPARATOR
Intervention: Electromyogram-triggered neuromuscular electrical stimulation
Number of subjects: 68
Study: 28873050

Group type: EXPERIMENTAL
Intervention: Video animation discharge instruction (6-minute video on proper usage of opioids)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Standard of care (verbal instruction and informational sheet)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Video animation discharge instruction
Number of subjects: 52

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Implementation of video discharge instruction
Number of subjects: 52
Study: 26777124

Group type: EXPERIMENTAL
Intervention: Accelerated radiotherapy (AF) - 1.1+2.0 Gy/day, 5 days/week in 35 days, total dose 68 Gy
Number of subjects: 750

Group type: COMPARATOR
Intervention: Conventional radiotherapy (CF) - 2 Gy/day, 5 days/week in 49 days, total dose 68 Gy
Number of subjects: 750
Study: 24421638

Group type: EXPERIMENTAL
Intervention: Self-care telephone intervention (first meeting with health professionals and five additional self-care telephone calls)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no intervention or attention, only questionnaires)
Number of subjects: 30
Study: 23342612

Group type: EXPERIMENTAL
Intervention: Solifenacin 5 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 20518928

Group type: EXPERIMENTAL
Intervention: Sonicare CanalBrush irrigation with 17% EDTA for 1 min, extended by 30 s with sonic agitation (group V)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 17% EDTA irrigation (group III and IV)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group I: 2 mL of distilled water
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group II: 2.5% NaOCl
Number of subjects: 50
Study: 18507596

Group type: EXPERIMENTAL
Intervention: Computer-generated humidity strategy
Number of subjects: 136

Group type: COMPARATOR
Intervention: Nurse-determined humidity strategy
Number of subjects: 136
Study: 16162753

Group type: EXPERIMENTAL
Intervention: Interval-based inspiratory muscle training (IMT) combined with breathing retraining (BR)
Number of subjects: 27
Study: 14709187

Group type: EXPERIMENTAL
Intervention: Structured (STR) intervention
Number of subjects: 40

Group type: COMPARATOR
Intervention: Self-directed (SELF) intervention
Number of subjects: 40
Study: 10648375

Group type: EXPERIMENTAL
Intervention: Whole body air displacement plethysmography
Number of subjects: 32

Group type: COMPARATOR
Intervention: Hydrodensitometry
Number of subjects: 32
Study: 9162604

Group type: EXPERIMENTAL
Intervention: Lipid-lowering drugs in patients with CHD and serum cholesterol >5.5 mmol I(‐1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Consider lipid-lowering drugs in patients without CHD when serum cholesterol exceeds 6.5 mmol I(‐1) and CHD risk >20% over the next 10 years
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary therapy aimed at decreasing fat intake, particularly saturated fat, and weight reduction in the obese
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Improvement of glycaemic control in patients with raised lipids
Number of subjects: 0
Study: 1899582

Group type: EXPERIMENTAL
Intervention: Alteplase (recombinant tissue plasminogen activator)
Number of subjects: 436

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Alteplase
Number of subjects: 436
Study: 6395938

Group type: EXPERIMENTAL
Intervention: Hydrocolloid dressing (HCD)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Silver sulfadiazine (1 percent)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Human allografts
Number of subjects: 24
Study: 31545867

Group type: EXPERIMENTAL
Intervention: Manual capsulorhexis
Number of subjects: 30

Group type: COMPARATOR
Intervention: 25-gauge vitrectorhexis
Number of subjects: 30
Study: 29708630

Group type: COMPARATOR
Intervention: Topical timolol 0.5% cream
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Intralesional injection of diprospan combined with topical timolol 0.5% cream
Number of subjects: 38
Study: 26079636

Group type: EXPERIMENTAL
Intervention: Anodal tDCS combined with occupational therapy
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham tDCS combined with occupational therapy
Number of subjects: 15
Study: 24763401

Group type: EXPERIMENTAL
Intervention: Early treatment response assessed by leukemic blast counts in bone marrow on day 28 after first reinduction.
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Early treatment response assessed by leukemic blast counts in bone marrow on day 15 after first reinduction.
Number of subjects: 338
Study: 22736248

Group type: EXPERIMENTAL
Intervention: Experimental trial with breathing system clamping PET CO2 at 50 mmHg
Number of subjects: 9

Group type: COMPARATOR
Intervention: Poikilocapnic control trial
Number of subjects: 9
Study: 20370481

Group type: EXPERIMENTAL
Intervention: Immediate circumcision
Number of subjects: 210

Group type: COMPARATOR
Intervention: Delayed circumcision (Control)
Number of subjects: 210
Study: 17109859

Group type: EXPERIMENTAL
Intervention: Outpatient Thermachoice III with ibuprofen 800 mg pre-treatment and nitrous oxide rescue analgesia
Number of subjects: 73

Group type: COMPARATOR
Intervention: Daycase Thermachoice III with general anesthesia and fentanyl/diclofenac
Number of subjects: 73
Study: 16331821

Group type: EXPERIMENTAL
Intervention: TCI remifentanil‐propofol (remifentanil at 6 microg/L and propofol at 3 mg/L)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: TCI remifentanil‐propofol
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (fentanyl 2.5 microg/kg and propofol 1‐2 mg/kg, maintained with fentanyl 0.03 microg.kg(‐1).min(‐1) and 1% isoflurane)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 12082493

Group type: EXPERIMENTAL
Intervention: Heart rate measurement after 5, 10, and 15 minutes in a sitting position
Number of subjects: 2230

Group type: EXPERIMENTAL
Intervention: Multiple regression analysis
Number of subjects: 2230

Group type: EXPERIMENTAL
Intervention: Blood pressure measurement
Number of subjects: 2230
Study: 9862539

Group type: EXPERIMENTAL
Intervention: Percutaneous intramuscular stimulation
Number of subjects: 6

Group type: COMPARATOR
Intervention: Surface stimulation
Number of subjects: 6
Study: 7839545

Group type: EXPERIMENTAL
Intervention: Salmeterol 50 micrograms (b.i.d.)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Salbutamol 400 micrograms (q.i.d.)
Number of subjects: 92
Study: 2817074

Group type: EXPERIMENTAL
Intervention: Added-purpose occupational form (stirring cookie dough)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Rote exercise condition (no added purpose)
Number of subjects: 30
Study: 788465

Group type: EXPERIMENTAL
Intervention: Pervincamine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 30
Study: 30973188

Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Dexamethasone 1 mg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Dexamethasone 2 mg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Dexamethasone 3 mg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Dexamethasone 4 mg
Number of subjects: 80
Study: 28665880

Group type: EXPERIMENTAL
Intervention: Home-based HIV counselling and testing (HCT)
Number of subjects: 15456
Study: 25308155

Group type: EXPERIMENTAL
Intervention: Self-instructional video
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Air cushion rim mask
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Round mask with two point top hold
Number of subjects: 0
Study: 23082002

Group type: EXPERIMENTAL
Intervention: Vismodegib (150 mg/day orally) with FOLFOX or FOLFIRI plus bevacizumab (5 mg/kg every 2 weeks)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Placebo with FOLFOX or FOLFIRI plus bevacizumab (5 mg/kg every 2 weeks)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Vismodegib
Number of subjects: 199
Study: 16796300

Group type: EXPERIMENTAL
Intervention: Closed-set tests of spoken word recognition with highly confusable foils
Number of subjects: 0

Group type: COMPARATOR
Intervention: Open-set tasks
Number of subjects: 0
Study: 12564607

Group type: EXPERIMENTAL
Intervention: Sibenadet 400 microg
Number of subjects: 1573

Group type: EXPERIMENTAL
Intervention: Sibenadet 600 microg
Number of subjects: 1573

Group type: EXPERIMENTAL
Intervention: Sibenadet 1000 microg
Number of subjects: 1573

Group type: EXPERIMENTAL
Intervention: Sibenadet 45 microg
Number of subjects: 1573

Group type: EXPERIMENTAL
Intervention: Sibenadet 270 microg
Number of subjects: 1573

Group type: EXPERIMENTAL
Intervention: Sibenadet 495 microg
Number of subjects: 1573

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1573

Group type: COMPARATOR
Intervention: Salbutamol 200 microg
Number of subjects: 1573

Group type: COMPARATOR
Intervention: Ipratropium bromide 40 microg
Number of subjects: 1573
Study: 10992168

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin therapy
Number of subjects: 19
Study: 8772731

Group type: EXPERIMENTAL
Intervention: Intensified Conventional Insulin Treatment (ICT)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Standard Insulin Treatment (ST)
Number of subjects: 59
Study: 1595825

Group type: EXPERIMENTAL
Intervention: Remedial group (n = 22) received individual training with parquetry block assembly
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Adaptive group (n = 23) received individual training in food preparation activities
Number of subjects: 45
Study: 6529680

Group type: EXPERIMENTAL
Intervention: Midazolam 0.2 mg X kg‐1
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Midazolam 0.4 mg X kg‐1
Number of subjects: 40
Study: 31801562

Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DP)
Number of subjects: 334

Group type: COMPARATOR
Intervention: Comparison of AL and DP
Number of subjects: 334
Study: 28194841

Group type: EXPERIMENTAL
Intervention: Sildenafil treatment in HFpEF patients
Number of subjects: 187
Study: 26464415

Group type: EXPERIMENTAL
Intervention: EA (Electroacupuncture at LI4)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: EA+LA (Electroacupuncture after injection of local anaesthetics)
Number of subjects: 12

Group type: COMPARATOR
Intervention: EA+NB (Electroacupuncture after blockade of the brachial plexus)
Number of subjects: 12
Study: 24263121

Group type: EXPERIMENTAL
Intervention: Atropine (0.2-1 mg) during DSE
Number of subjects: 45

Group type: COMPARATOR
Intervention: Dobutamine without atropine (control group)
Number of subjects: 45
Study: 21864414

Group type: EXPERIMENTAL
Intervention: Psycho-social intervention consisting of 12 sessions of structured social support, problem solving techniques, group discussions, and trainer-supervised relaxation exercises (twice per week over six weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psycho-social intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 0
Study: 19212235

Group type: EXPERIMENTAL
Intervention: Immediately loaded dental implants
Number of subjects: 12

Group type: COMPARATOR
Intervention: Conventionally loaded dental implants
Number of subjects: 12
Study: 17286529

Group type: EXPERIMENTAL
Intervention: Stepped-care intervention
Number of subjects: 607

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 607
Study: 15109187

Group type: EXPERIMENTAL
Intervention: Omeprazole 60 mg
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control (neither intervention)
Number of subjects: 75
Study: 11555565

Group type: EXPERIMENTAL
Intervention: 300 mg aerosolized tobramycin solution for inhalation (TSI) administered twice daily for 4 weeks
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: 300 mg aerosolized tobramycin solution for inhalation (TSI)
Number of subjects: 74
Study: 9683313

Group type: EXPERIMENTAL
Intervention: Community intervention campaign of public and professional education during an 18-month intervention period.
Number of subjects: 600

Group type: COMPARATOR
Intervention: Control communities (no intervention).
Number of subjects: 600
Study: 8113547

Group type: EXPERIMENTAL
Intervention: Naloxone infusion
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 43
Study: 3183476

Group type: EXPERIMENTAL
Intervention: Balloon dilatation of the pouch and sphincter biofeedback training
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40
Study: 31295717

Group type: EXPERIMENTAL
Intervention: MODAFINIL
Number of subjects: 36

Group type: COMPARATOR
Intervention: PLACEBO
Number of subjects: 36
Study: 28559456

Group type: EXPERIMENTAL
Intervention: 3-month, supervised and individually tailored modular multimodal exercise programme with spinal isometric training
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual medical care
Number of subjects: 40
Study: 26332527

Group type: EXPERIMENTAL
Intervention: Trametinib plus dabrafenib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vemurafenib
Number of subjects: 0
Study: 23923408

Group type: EXPERIMENTAL
Intervention: Methotrexate (10 mg) single morning dose
Number of subjects: 44

Group type: COMPARATOR
Intervention: Mini pulse betamethasone (5 mg) single morning dose on 2 consecutive days
Number of subjects: 44
Study: 21393112

Group type: EXPERIMENTAL
Intervention: Exclusive breastfeeding for 6 months
Number of subjects: 204

Group type: COMPARATOR
Intervention: Partially breastfed
Number of subjects: 204

Group type: COMPARATOR
Intervention: Non-breastfed
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Exclusive breastfeeding
Number of subjects: 204

Group type: COMPARATOR
Intervention: Partially breastfed and non-breastfed
Number of subjects: 204
Study: 19504119

Group type: EXPERIMENTAL
Intervention: Maximal strength training (MST)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 19
Study: 16515981

Group type: EXPERIMENTAL
Intervention: Baseline PSA less than 1 ng/ml
Number of subjects: 30495

Group type: EXPERIMENTAL
Intervention: Baseline PSA 1.0 to 1.99 ng/ml
Number of subjects: 30495

Group type: EXPERIMENTAL
Intervention: Baseline PSA 2.0 to 2.99 ng/ml
Number of subjects: 30495

Group type: EXPERIMENTAL
Intervention: Baseline PSA 3.0 to 4.0 ng/ml
Number of subjects: 30495

Group type: EXPERIMENTAL
Intervention: Men with baseline PSA less than 1 ng/ml converting to PSA more than 4 ng/ml
Number of subjects: 30495

Group type: EXPERIMENTAL
Intervention: Men with baseline PSA less than 1 ng/ml and negative baseline DRE
Number of subjects: 30495
Study: 15295729

Group type: EXPERIMENTAL
Intervention: AED1
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: AED2
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: AED3
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: AED4
Number of subjects: 64

Group type: COMPARATOR
Intervention: All AEDs
Number of subjects: 64
Study: 10691220

Group type: EXPERIMENTAL
Intervention: M‐6‐G 0.1 mg/kg
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Morphine 0.15 mg/kg
Number of subjects: 37
Study: 9488217

Group type: EXPERIMENTAL
Intervention: Acetylcholine (ACh) at doses of 0.3, 1.0, and 3.0 microg/kg per min
Number of subjects: 20

Group type: COMPARATOR
Intervention: Atropine at doses of 100 and 300 ng/kg per min
Number of subjects: 20
Study: 8442923

Group type: EXPERIMENTAL
Intervention: Chemotherapy (tinidazole, thiabendazole, and cotrimoxazole)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 3510393

Group type: EXPERIMENTAL
Intervention: Chloroquine (300 mg per week)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control (no chloroquine)
Number of subjects: 51
Study: 29914406

Group type: EXPERIMENTAL
Intervention: Management strategies by general practitioners (GPs) during MUS consultations, including history-taking, physical examination (24.5%), additional investigations by the GP (11.1%), prescribing medication (24.6%), and providing explanations (11.2%).
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Management strategies by GPs, including exploration of all complaint dimensions (3.5%), referral to a psychologist (0.5%), or psychiatrist (0.1%).
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Overall management of MUS by Dutch GPs.
Number of subjects: 77
Study: 27513903

Group type: EXPERIMENTAL
Intervention: Smartphone ophthalmoscopy
Number of subjects: 110

Group type: COMPARATOR
Intervention: Slit-lamp biomicroscopy
Number of subjects: 110
Study: 24919867

Group type: EXPERIMENTAL
Intervention: Flexible imputation strategy for missing data in SMARTs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Data from the Clinical Antipsychotic Trial of Intervention and Effectiveness
Number of subjects: 0
Study: 22268960

Group type: EXPERIMENTAL
Intervention: Individualized e-health intervention (e-consultation, patient-tailored website, monitoring, and self-management training)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Usual face-to-face care (control group)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Individualized e-health intervention
Number of subjects: 199
Study: 20651386

Group type: EXPERIMENTAL
Intervention: Radical loop electrosurgical excision procedure (LLETZ)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Prospective follow‐up without treatment
Number of subjects: 90
Study: 18614918

Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART) adherence measured through pill usage and questionnaire.
Number of subjects: 2957

Group type: EXPERIMENTAL
Intervention: Complete adherence (100% drug possession ratio).
Number of subjects: 2957

Group type: EXPERIMENTAL
Intervention: Factors associated with adherence.
Number of subjects: 2957
Study: 16212581

Group type: EXPERIMENTAL
Intervention: CAF+EMD
Number of subjects: 15

Group type: COMPARATOR
Intervention: CAF only
Number of subjects: 15
Study: 12626218

Group type: EXPERIMENTAL
Intervention: 5-cm² Estradot patch (50 micro g/day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: 12.5-cm² Climara patch
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 5-cm² Estradot patch
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both patches
Number of subjects: 100
Study: 10652894

Group type: EXPERIMENTAL
Intervention: Nimesulide (100 mg) tablets administered twice daily
Number of subjects: 180

Group type: COMPARATOR
Intervention: Diclofenac (50 mg) tablets administered thrice daily
Number of subjects: 180
Study: 8908281

Group type: EXPERIMENTAL
Intervention: Alternaria
Number of subjects: 0

Group type: COMPARATOR
Intervention: Candida
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspergillus
Number of subjects: 0
Study: 1680885

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine 30 mg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Methylphenidate 40 mg
Number of subjects: 11

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 11
Study: 6753711

Group type: EXPERIMENTAL
Intervention: Volar V‐Y advancement
Number of subjects: 200

Group type: COMPARATOR
Intervention: Cross‐finger flap
Number of subjects: 200

Group type: COMPARATOR
Intervention: Simple dressing
Number of subjects: 200

Group type: COMPARATOR
Intervention: Other methods (split skin grafting, full‐thickness skin grafting, Kutler's bilateral V‐Y advancement, revision amputation)
Number of subjects: 200
Study: 31695864

Group type: EXPERIMENTAL
Intervention: MART (maintenance and reliever therapy)
Number of subjects: 1701

Group type: COMPARATOR
Intervention: prn salbutamol
Number of subjects: 1701
Study: 29193710

Group type: EXPERIMENTAL
Intervention: Scopolamine ointment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 25172200

Group type: EXPERIMENTAL
Intervention: Gentamicin-collagen sponges (GCS)
Number of subjects: 291

Group type: COMPARATOR
Intervention: Collagen sponge without antibiotics
Number of subjects: 291

Group type: COMPARATOR
Intervention: No sponge (control group)
Number of subjects: 291
Study: 24052204

Group type: EXPERIMENTAL
Intervention: Culturally tailored diabetes intervention with community health workers (CHWs)
Number of subjects: 104
Study: 21453895

Group type: EXPERIMENTAL
Intervention: AEP monitoring (group A)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Judgment of clinical signs (group B)
Number of subjects: 170
Study: 18281394

Group type: EXPERIMENTAL
Intervention: Lay educator
Number of subjects: 567

Group type: COMPARATOR
Intervention: Practice nurse
Number of subjects: 567

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 567
Study: 16585864

Group type: EXPERIMENTAL
Intervention: Lidocaine block of the recurrent laryngeal nerve
Number of subjects: 21
Study: 11907654

Group type: EXPERIMENTAL
Intervention: Rapid fat infusion over 6 h (rFI)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Slow fat infusion over 24 h (sFI)
Number of subjects: 18
Study: 10208786

Group type: EXPERIMENTAL
Intervention: Intra-aortic balloon pump therapy
Number of subjects: 238

Group type: COMPARATOR
Intervention: No intra-aortic balloon pump therapy
Number of subjects: 238
Study: 9497628

Group type: EXPERIMENTAL
Intervention: tranexamic acid mouthwash
Number of subjects: 24

Group type: COMPARATOR
Intervention: systemic tranexamic acid (control)
Number of subjects: 24
Study: 2365119

Group type: EXPERIMENTAL
Intervention: Piperacillin or Mezlocillin (single-dose prophylaxis)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Radical vulvectomy (control group)
Number of subjects: 48
Study: 330077

Group type: EXPERIMENTAL
Intervention: timolol (20, 40, and 60 mg daily)
Number of subjects: 18

Group type: COMPARATOR
Intervention: propranolol (0.2 mg/kg intravenously)
Number of subjects: 18

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 18
Study: 7245774

Group type: EXPERIMENTAL
Intervention: 300 mg slow-release allopurinol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal release allopurinol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Slow-release allopurinol
Number of subjects: 0